Skip to main content
EJNMMI Research
Fig. 1 | EJNMMI Research

Fig. 1

From: Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype

Fig. 1

Patient example. Example of a patient with a 22-mm HER2-positive invasive carcinoma of no special type in her left breast. An axial 18F-FDG PET/CT exam of the left axilla shows the most FDG-avid axillary lymph node with an SUVmax of 7.37. Following completion NST, this patient had residual axillary disease

Back to article page